# Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions

> **NCT02127827** · NA · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days.
- To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor.
- To Evaluate the User Experience With a Closed Loop System

## Interventions

- **DEVICE:** Automated Ambulatory Glycemic Controller (AAGC)

## Key facts

- **NCT ID:** NCT02127827
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02127827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02127827, "Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02127827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*